Background & Aims The association between sarcopenia and prognosis in patients with
cirrhosis remains to be determined. In this study, we aimed to quantify the association …

Background Sarcopenia is a common syndrome in chronic diseases such as liver cirrhosis.
The association between sarcopenia and outcomes, such as complications and survival has …

Background: Sarcopenia is now recognized more and more as a biomarker with poor
outcomes in cirrhotic patients. Aims: The purpose of this study was to investigate the …

Background Diagnostic criteria for sarcopenia have not been established in Chinese. This
study established criteria based on the L3‐skeletal muscle index (L3‐SMI) and assessed its …

Skeletal muscle is the largest organ in the body, and skeletal muscle atrophy results from a
shift in the balance of protein synthesis and degradation toward protein breakdown. Primary …

Patients with liver cirrhosis and, in particular, those with liver failure are at high risk of
reduced muscle mass and strength/function, otherwise known as sarcopenia. Sarcopenia is …

The most commonly recognized complications in cirrhotic patients include ascites, hepatic
encephalopathy, variceal bleeding, susceptibility for infections, kidney dysfunction, and …

Introduction: Sarcopenia is a syndrome characterized by progressive and generalized loss
of skeletal muscle mass and strength, which is commonly associated with various chronic …

BACKGROUND & AIMS: Sarcopenia, defined as a low level of muscle mass, occurs in
patients with cirrhosis. We assessed its incidence among cirrhotic patients undergoing …

In patients with decompensated cirrhosis, sarcopenia and frailty are prevalent. Although
several definitions exist for these terms, in the field of hepatology, sarcopenia has commonly …